Insmed (INSM) SVP Samuele Butera files Form 3 showing no trades

Rhea-AI Filing Summary

INSMED Inc executive files initial insider report with no transactions. Samuele Butera, listed as SVP, GM, Global Respiratory at INSMED Inc, is identified as a reporting person on a Form 3. The filing shows zero buy, sell, acquisition, or disposition transactions, and no derivative positions or holdings are reported.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/24/2026 - 04:13 PM Accepted by SEC EDGAR 06/24/2026 - 04:12 PM Learn about SEC filing dates

FAQ

Who is the reporting person in the Insmed (INSM) Form 3 filing?

The reporting person is Samuele Butera, identified as SVP, GM, Global Respiratory at INSMED Inc. He is not listed as a director or ten percent owner in this insider ownership report.

Does this Insmed (INSM) Form 3 report any share transactions?

No, this Form 3 reports no share transactions. The transaction summary shows zero buys, zero sells, zero acquisitions or dispositions, and zero derivative transactions for the reporting person.

Are any derivative securities disclosed for Samuele Butera in this Form 3?

No derivative securities are disclosed for Samuele Butera in this Form 3. The derivativeSummary section is empty and the derivativeTransactionCount in the transaction summary is zero.

Does the Insmed (INSM) Form 3 show any holdings for the reporting person?

The Form 3 shows no reported holdings for the reporting person. The transaction summary indicates zero holding entries, meaning no specific share or derivative positions are listed in this filing excerpt.

Is Samuele Butera reported as a ten percent owner of Insmed (INSM)?

No, Samuele Butera is not reported as a ten percent owner. The filing flags him as an officer with the title SVP, GM, Global Respiratory, and the ten percent owner indicator is set to zero.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Butera Samuele

(Last) (First) (Middle)

700 US HIGHWAY 202/206

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/23/2026

3. Issuer Name and Ticker or Trading Symbol
INSMED Inc [ INSM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GM, Global Respiratory

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Samuele Butera, by Michael A. Smith as Attorney-in-fact	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)